New Molecules for the Re-Activation of Haemoglobin (Hb) F in the Treatment of Sickle Cell Disease and Thalassemia - New Molecules for the Re-Activation of Haemoglobin (Hb) F in the Treatment of Sickle Cell Disease and Thalassemia
End date:
31 December 2021